- Sunovion Announces U.S. FDA Approval of KYNMOBI™ (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes
- Sunovion Discontinues Dasotraline Program
- New England Journal of Medicine Publishes Pivotal Results Evaluating Sunovion’s SEP-363856 for the Treatment of Schizophrenia
As of last trade,
Sumitomo Chemical Co Ltd (4005:TYO) traded at 341.00, 27.72% above the 52 week low of 267.00 set on Mar 17, 2020.
267.00Mar 17 2020524.00Nov 11 2019
Markit short selling activity
|Market cap||571.13bn JPY|
|EPS (TTM)||18.84 |
|Annual div (ADY)||17.00 |
|Annual div yield (ADY)||4.93%|
|Div ex-date||Mar 30 2020|
|Div pay-date||Jun 09 2020|
Data delayed at least 20 minutes, as of May 29 2020 02:01 BST.